Form 4: Omnicell CEO Randall Lipps Reports Routine Tax-Related Stock Disposition

Omnicell, Inc.'s Chairman, President, and CEO, Randall A. Lipps, reported the disposition of 1,146 shares of common stock at $29.25 per share to cover tax obligations related to restricted stock unit vesting.

Summary

• Randall A. Lipps, Chairman, President, and CEO of Omnicell, Inc. (OMCL), filed a Form 4 with the SEC.
• The filing reports a transaction on June 15, 2025, involving the disposition of 1,146 shares of Omnicell common stock.
• The shares were disposed of at a price of $29.25 per share.
• This transaction was coded 'F', indicating it was a withholding of shares to cover taxes due in connection with the vesting of restricted stock units.
• Following this transaction, Mr. Lipps directly holds 403,523 shares of common stock.
• Additionally, Mr. Lipps indirectly holds 355,861 shares in trust with his wife and 8,051 shares in trust for his children.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, non-discretionary transaction (tax withholding) by an insider, which typically has no material impact on the company's operations or stock valuation.

Future Outlook

This document does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide information related to broader industry trends or competitive landscape within the healthcare technology or pharmacy automation sectors where Omnicell operates.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and does not reflect a change in investment sentiment by the insider.
• Employees: No direct impact.

Key Dates

Keywords

Omnicell, OMCL, Randall Lipps, SEC Form 4, Insider Trading, Stock Disposition, Restricted Stock Units, Tax Withholding, Corporate Governance, Executive Compensation